sulbactam has been researched along with Aging in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Enoki, Y; Ikawa, K; Matsubara, K; Matsumoto, K; Morikawa, N; Ohshige, T; Shigemi, A; Takeda, Y; Terazono, H; Watanabe, E; Yokoyama, Y | 1 |
| de la Pena, A; Derendorf, H | 1 |
| Bawdon, RE; Castle, S; Jones, A; Norman, DC; Rho, JP; Smith, K; Woo, M | 1 |
1 review(s) available for sulbactam and Aging
| Article | Year |
|---|---|
Pharmacokinetic properties of beta-lactamase inhibitors.
Topics: Absorption; Aging; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biological Availability; Clavulanic Acid; Drug Synergism; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Sulbactam; Tazobactam | 1999 |
2 other study(ies) available for sulbactam and Aging
| Article | Year |
|---|---|
Dosing Optimization of Ampicillin-Sulbactam Based on Cystatin C in Elderly Patients with Pneumonia.
Topics: Aged; Aged, 80 and over; Aging; Ampicillin; Anti-Bacterial Agents; Cystatin C; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Models, Biological; Pneumonia; Renal Elimination; Sulbactam | 2021 |
Single-dose pharmacokinetics of intravenous ampicillin plus sulbactam in healthy elderly and young adult subjects.
Topics: Adult; Aged; Aging; Ampicillin; Female; Half-Life; Humans; Injections, Intravenous; Male; Sulbactam | 1989 |